GI Dynamics® Inc. (ASX:GID) is the developer of EndoBarrier®, the first endoscopically delivered medical device for the treatment of type 2 diabetes and the reduction of obesity. EndoBarrier is not approved for sale and is limited by federal law to investigational use only. EndoBarrier is subject to an Investigational Device Exemption by the FDA in the United States and is entering concurrent pivotal trials in the United States and India.
Company profile
Ticker
GIDYL
Exchange
Website
CEO
Scott W. Schorer
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
GI DYNAMICS INC
SEC CIK
Corporate docs
GIDYL stock data
Latest filings (excl ownership)
SC 13E3/A
Going private transaction (amended)
2 Aug 21
15-12G
Securities registration termination
21 Jul 21
8-K
Material Modifications to Rights of Security Holders
20 Jul 21
DEF 14C
Information statement
25 Jun 21
SC 13E3/A
Going private transaction (amended)
25 Jun 21
SC 13E3
Going private transaction
15 Jun 21
PRE 14C
Preliminary information
11 Jun 21
10-K/A
2020 FY
Annual report (amended)
11 Jun 21
10-Q
2021 Q1
Quarterly report
7 May 21
8-K
Entry into a Material Definitive Agreement
1 Apr 21
Latest ownership filings
Financial summary
Quarter (USD) | Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 961.00 k | 961.00 k | 961.00 k | 961.00 k | 961.00 k | 961.00 k |
Cash burn (monthly) | 76.00 k | 243.58 k | 789.67 k | 887.08 k | 580.00 k | 778.67 k |
Cash used (since last report) | 2.80 mm | 8.97 mm | 29.09 mm | 32.68 mm | 21.37 mm | 28.69 mm |
Cash remaining | -1.84 mm | -8.01 mm | -28.13 mm | -31.72 mm | -20.41 mm | -27.73 mm |
Runway (months of cash) | -24.2 | -32.9 | -35.6 | -35.8 | -35.2 | -35.6 |
Institutional ownership, Q3 2019
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|